Benchmarks
Nifty23,921.15170.96
The Economic Times
English EditionEnglish Editionहिन्दीગુજરાતીमराठीবাংলাಕನ್ನಡമലയാളംதமிழ்తెలుగు
| 27 December, 2024, 10:21 AM IST | Today's ePaper
My Watchlist
Business News›Markets›Stocks›Stock Price Quotes›Alkem Laboratories Share Price › Alkem Laboratories History

    Alkem Labs History

    BSE:539523  |  NSE:ALKEMEQ  |  IND:Pharma - Indian  |  ISIN code:INE540L01014  |  SECT:Pharmaceuticals

    PREMARKET

    BSE 

    Change:

    Volume:

    Open:

    Prv. Close:

    Today:

    Alkem Laboratories Ltd.

    52-Wk:

    Alkem Laboratories Ltd.

    Bid:

    ()

    Offer:

    ()

    NSE 

    Change:

    Volume:

    Open:

    Prv. Close:

    Today:

    Alkem Laboratories Ltd.

    52-Wk:

    Alkem Laboratories Ltd.

    Bid:

    ()

    Offer:

    ()

    The Company History page lists out the major events in chronological order for Alkem Laboratories Ltd.

    Company History - Alkem Laboratories Ltd.
    The Company was incorporated as a private limited company ‘Alkem Laboratories Private Limited’ on August 8,1973 at Patna under the Companies Act, 1956 and subsequently became a deemed public limited company under section 43A(2) of Companies Act, 1956 on October 26, 1988. Pursuant to the Company passing a resolution under section 21 of Companies Act, 1956 and upon issuance of a fresh certificate of incorporation consequent on change of name dated August 21, 2001, the name of the Company was changed to ‘Alkem Laboratories Limited’ with effect from October 26, 1988. the registered office was originally located at ‘Exhibition Road, Patna – 800 001, Bihar, India’. the Company filed Company Petition No. 356(17)/ ERB/ 2007 before the Company Law Board, Eastern Region Bench at Kolkata for shifting the registered office of the Company from the State of Bihar to the State of Maharashtra, as approved by a special resolution at its extra-ordinary general meeting held on January 29, 2007. The Company Law Board, Eastern Region Bench at Kolkata passed an order dated July 30, 2007 whereby it confirmed the alteration of the situation clause in the Memorandum of Association, from the State of Bihar to the State of Maharashtra. Pursuant to the order, the registered office of the Company was shifted to ‘Alkem House, Senapati Bapat Marg, Lower Parel, Mumbai – 400 013, Maharashtra, India’ with effect from August 2, 2007.







    Major Events :



    1973



    -Incorporation of the Company.



    1978



    -the Company established its first plant at Taloja, Maharashtra.



    1988



    -the Company became a deemed public limited company.



    1992



    -the Company established its manufacturing facility in Mandwa, Maharashtra. This facility was converted into an API facility in 2005.



    1998



    -the Company established its Kachigam manufacturing facility in Gujarat.



    2001



    -Startronic Pharmachem Private Limited and Indo Propkem amalgamated with the Company.



    2002



    -the Company established its Amaliya manufacturing facility in Gujarat.



    2003



    -the Company set up its research and development facility at Taloja, Maharashtra.



    2005



    -the Company established its manufacturing facility in Baddi, Himachal Pradesh.



    2006



    -the anti-infective drug Taxim became the first drug in the Indian pharmaceutical industry to cross 1,000 million in terms of domestic sales in India (Source: IMS Research)



    2007



    -the Company established its manufacturing facility in Kumrek, Sikkim.



    -the Company filed its first ANDA in the United States for the drug, Amlodipine.



    -the Company shifted its Registered Office from Patna, Bihar to Mumbai, Maharashtra.



    2009



    -the Company acquired Pharmacor, a generic pharma company in Australia.



    2010



    -the Company acquired The PharmaNetwork, LLC, the holding company of Ascend Laboratories LLC.



    2011



    -the Company acquired Enzene Bio sciences Limited.



    2012



    -the Company acquired an API manufacturing facility in the United States.



    2014



    -the Company acquired the Clindac.



    2015



    -the Company acquired a formulation manufacturing facility in the United States.





    Awards and achievements:



    2002



    -the Company was awarded the Pharma Business and Technology Excellence Award in 2002 as 'India’s Most Esteemed Pharmaceutical Company'



    2004



    -the product Taxim was awarded the Pharma Business and Technology Excellence Award for successful brand in 2004



    2005



    -the Company was awarded the Overall Performance Award for Group B at the 5th Express Pharma Awards in 2005



    2009



    -the Company received a certificate of appreciation for outstanding export performance in the category of formulations by the Pharmaceuticals Export Promotion Council of India, supported by Ministry of Commerce and Industry, GOI



    -the Company received the certificate of appreciation in the category of ‘Formulation Experts’ by the Pharmaceuticals Export Promotion Council of India, supported by Ministry of Commerce and Industry, GOI



    2013

    -the Company was awarded the India’s most admired pharma company award for 2013 at the 6th Annual Pharmaceutical Leadership Summit in 2013



    2014

    -the Product ‘Clavam’ was awarded as the ‘ Brand of the Year’ at the AWACS Award, 2014



    2016

    -Alkem's Mandva Plant successfully obtains the Establishment Inspection Report from the US FDA

    -Alkem receives EIR from the US FDA for its Daman formulation facility

    Nifty 50 Stocks

    Top Gainer Stocks

    Top Loser Stocks

    Most Searched Stocks

    Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
    BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
    By using this site, you agree to the Terms of Service and Privacy Policy.

    The Economic Times
    BrowseCompanies:
      翻译：